US FDA approves ILUMYA for adults with active psoriatic arthritis Approval expands the drug’s use beyond moderate-to-severe plaque […]
IIM Ahmedabad Summer Placements 2026–27: Top recruiters, 160-plus roles and global career opportunities converge on campus
TWO CLUSTERS, 160-PLUS ROLES: Consulting, investment banking, consumer goods, healthcare, technology-enabled services and multiple other sectors feature in […]
Bonfiglioli’s ₹2,534-Crore IPO: A 70-year global engineering legacy all set to power investor appetite
IPO opens October 15: Price band fixed at ₹558–586; subscription closes October 19 Anchor book attracts ₹759.26 crore: […]
MSMEs set for a national deal-making rendezvous as UDYAM 2026 brings 500+ exhibitors to Gujarat
Four-day industrial showcase: 15th India Industrial Fair – UDYAM 2026 to be held at the Helipad Exhibition Centre, […]
Cadila Pharmaceuticals earns Asia Book of Records recognition for nationwide doctor engagement initiative
Achieved Global Milestone with Mass Graphology Campaign for Indian Medical Fraternity An Initiative Celebrating Clinicians’ Selfless Service and […]
Eat healthy, live longer: Your DNA knows. your lifestyle writes the next chapter
Bio-Synergy brings DNA + Epigenetics testing to India, turning preventive health into a personalised conversation Ahmedabad launch puts […]
Sun Pharma secures global rights to monthly cholesterol drug; Lerodalcibep opens door to $3.7-Bn PCSK9 market
Exclusive rights outside US, China cover commercialisation and manufacturing of lerodalcibep EU-approved Lyrokaul offers once-monthly dosing and up […]
Where Healthcare Meets Opportunity: Gujarat Medical Expo 2026 puts innovation, procurement & partnerships under one roof
2nd edition of Gujarat Medical Expo to bring India’s medical and healthcare ecosystem together at Ahmedabad’s Vigyan Bhavan […]
Posting: Eris Lifesciences bolsters Board with private equity veteran Akhil Awasthi
Three-decade investment and healthcare experience comes to Eris Board Former Tata Capital Growth Fund and Baring PE executive […]
Biocon’s Pertuzumab breakthrough: first biosimilar to win EMA panel nod under tailored clinical approach
NE HEALTH BUREAU CHENNAI, SEPT 21 Biocon has achieved a significant regulatory milestone in the development of biosimilar […]
